Maa: Taiwan
Kieli: kiina
Lähde: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
ISOLEUCINE;;LEUCINE;;LYSINE HCL;;METHIONINE;;PHENYLALANINE;;THREONINE;;TRYPTOPHAN;;VALINE;;ARGININE;;HISTIDINE;;ALANINE;;GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL);;ASPARTIC ACID;;GLUTAMIC ACID;;PROLINE;;SERINE;;TYROSINE;;SODIUM ACETATE TRIHYDRATE (EQ TO SODIUM ACETATE 3H2O );;SODIUM CHLORIDE;;SODIUM HYDROXIDE;;POTASSIUM ACETATE;;MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O);;SODIUM PHOSPHATE DIBASIC DODECAHYDRATE (EQ TO DISODIUM PHOSPHATE DODECAHYDRATE)
台灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106)
B05BA10
注射劑
POTASSIUM ACETATE (4008000100) MG; SODIUM ACETATE TRIHYDRATE (EQ TO SODIUM ACETATE 3H2O ) (4008000670) MG; MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O) (4012001550) MG; SODIUM CHLORIDE (4012002100) MG; ALANINE (4020100200) MG; ARGININE (4020100300) MG; ASPARTIC ACID (4020100400) MG; GLUTAMIC ACID (4020100700) MG; HISTIDINE (4020100900) MG; ISOLEUCINE (4020101000) MG; LEUCINE (4020101200) MG; LYSINE HCL (4020101310) (eq. to lysine 3.43mg)MG; METHIONINE (4020101500) MG; PHENYLALANINE (4020101700) MG; PROLINE (4020101800) MG; SERINE (4020101900) MG; THREONINE (4020102000) MG; TRYPTOPHAN (4020102100) MG; TYROSINE (4020102200) MG; VALINE (4020102300) MG; GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL) (4020102400) MG; SODIUM PHOSPHATE DIBASIC DODECAHYDRATE (EQ TO DISODIUM PHOSPHATE DODECAHYDRATE) (5612002607) MG; SODIUM HYDROXIDE (9600028200) MG
玻璃瓶裝
製 劑
限由醫師使用
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE 1, 34212 MELSUNGEN, GERMANY DE
combinations
無法經口服攝取食物或腸道吸收營養、功能不全或有禁忌症時,作為靜脈營養治療提供胺基酸和限量的電解質之補充。適用於成人、青少年和2歲以上兒童。
有效日期: 2025/04/13; 英文品名: Aminoplasmal Neo 5% E
2010-04-13
1. NAME OF THE MEDICINAL PRODUCT Aminoplasmal Neo 5% E 2. QUALITATIVE AND QUANTITATIVE COMPOSITION The solution for infusion contains: per 1 ml per 250 ml per 500 ml per 1000 ml Isoleucine 2.50 mg 0.63 g 1.25 g 2.50 g Leucine 4.45 mg 1.11 g 2.23 g 4.45 g Lysine hydrochloride 4.28 mg 1.07 g 2.14 g 4.28 g (equivalent to lysine) (3.43 mg) (0.86 g) (1.72 g) (3.43 g) Methionine 2.20 mg 0.55 g 1.10 g 2.20 g Phenylalanine 2.35 mg 0.59 g 1.18 g 2.35 g Threonine 2.10 mg 0.53 g 1.05 g 2.10 g Tryptophan 0.80 mg 0.20 g 0.40 g 0.80 g Valine 3.10 mg 0.78 g 1.55 g 3.10 g Arginine 5.75 mg 1.44 g 2.88 g 5.75 g Histidine 1.50 mg 0.38 g 0.75 g 1.50 g Alanine 5.25 mg 1.31 g 2.63 g 5.25 g Glycine 6.00 mg 1.50 g 3.00 g 6.00 g Aspartic acid 2.80 mg 0.70 g 1.40 g 2.80 g Glutamic acid 3.60 mg 0.90 g 1.80 g 3.60 g Proline 2.75 mg 0.69 g 1.38 g 2.75 g Serine 1.15 mg 0.29 g 0.58 g 1.15 g Tyrosine 0.40 mg 0.10 g 0.20 g 0.40 g Sodium acetate trihydrate 1.361 mg 0.340 g 0.681 g 1.361 g Potassium acetate 2.453 mg 0.613 g 1.227 g 2.453 g Sodium chloride 0.964 mg 0.241 g 0.482 g 0.964 g Sodium hydroxide 0.140 mg 0.035 g 0.070 g 0.140 g Magnesium chloride hexahydrate 0.508 mg 0.127 g 0.254 g 0.508 g Disodium phosphate dodecahydrate 3.581 mg 0.895 g 1.791 g 3.581 g _Electrolyte concentrations _ _ _ Sodium 50 mmol/l Potassium 25 mmol/l Magnesium 2.5 mmol/l Acetate 35 mmol/l Chloride 45 mmol/l Phosphate 10 mmol/l Citrate 1.0 – 2.0 mmol/l Total amino acids 50 g/l Total nitrogen 7.9 g/l For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for infusion Clear, colourless up to faintly straw-coloured aqueous solution. Energy [kJ/l (kcal/l)] 835 (200) Theoretical osmolarity [mOsm/l] 592 Acidity (titration to pH 7.4) [mmol NaOH/l] approx. 17 pH 5.7 – 6.3 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Supply of amino acids and a limited amount of electrolytes for paren- teral nutrition, when oral or enteral nutrition is impossible, insufficient or contraindicated. For adults, adolescents and children over 2 years of age. Lue koko asiakirja